143 related articles for article (PubMed ID: 37182749)
21. Synthesis, structural characterization, analytical profiling, and application to authentic samples of synthesized Phase I metabolites of the synthetic cannabinoid 5F-MDMB-PICA.
Chen RJ; Zhang ZH; Yang S; Yu SC; Wang JC; Liao PY; Qiu TT; Xiao L; Xue S; Chen H; Shao WB; Hu JW; Lan Y; Chen XL; Xu Y; Zhou TM; Zhao XJ; Liu WB
Drug Test Anal; 2024 Mar; ():. PubMed ID: 38488339
[TBL] [Abstract][Full Text] [Related]
22. Differential cannabinoid-like effects and pharmacokinetics of ADB-BICA, ADB-BINACA, ADB-4en-PINACA and MDMB-4en-PINACA in mice: A comparative study.
Zhou F; Wang X; Tan S; Shi Y; Xie B; Xiang P; Cong B; Ma C; Wen D
Addict Biol; 2024 Feb; 29(2):e13372. PubMed ID: 38380735
[TBL] [Abstract][Full Text] [Related]
23. Comparative pharmacokinetic and intracerebral distribution of MDMB-4F-BICA in mice following inhalation ('vapor') and subcutaneous injection.
Xu Y; Li X; Xu P; Yan F; Wang D
J Pharm Biomed Anal; 2024 Apr; 241():115988. PubMed ID: 38301574
[TBL] [Abstract][Full Text] [Related]
24. Simultaneous analysis of 29 synthetic cannabinoids and metabolites, amphetamines, and cannabinoids in human whole blood by liquid chromatography-tandem mass spectrometry - A New Zealand perspective of use in 2018.
Ong RS; Kappatos DC; Russell SGG; Poulsen HA; Banister SD; Gerona RR; Glass M; Johnson CS; McCarthy MJ
Drug Test Anal; 2020 Feb; 12(2):195-214. PubMed ID: 31595682
[TBL] [Abstract][Full Text] [Related]
25. Molecular and Behavioral Pharmacological Characterization of Abused Synthetic Cannabinoids MMB- and MDMB-FUBINACA, MN-18, NNEI, CUMYL-PICA, and 5-Fluoro-CUMYL-PICA.
Gamage TF; Farquhar CE; Lefever TW; Marusich JA; Kevin RC; McGregor IS; Wiley JL; Thomas BF
J Pharmacol Exp Ther; 2018 May; 365(2):437-446. PubMed ID: 29549157
[TBL] [Abstract][Full Text] [Related]
26. Identification of synthetic cannabinoids that were seized, consumed, or associated with deaths in Kuwait in 2018 using GC-MS and LC-MS-MS analysis.
Al-Matrouk A; Alqallaf M; AlShemmeri A; BoJbarah H
Forensic Sci Int; 2019 Oct; 303():109960. PubMed ID: 31550599
[TBL] [Abstract][Full Text] [Related]
27. Metabolites of Synthetic Cannabinoid 5F-MDMB-PINACA Retain Affinity, Act as High Efficacy Agonists and Exhibit Atypical Pharmacodynamic Properties at CB1 Receptors.
Cabanlong CV; Russell LN; Fantegrossi WE; Prather PL
Toxicol Sci; 2022 Apr; 187(1):175-185. PubMed ID: 35201352
[TBL] [Abstract][Full Text] [Related]
28. Pharmacology of Cumyl-Carboxamide Synthetic Cannabinoid New Psychoactive Substances (NPS) CUMYL-BICA, CUMYL-PICA, CUMYL-5F-PICA, CUMYL-5F-PINACA, and Their Analogues.
Longworth M; Banister SD; Boyd R; Kevin RC; Connor M; McGregor IS; Kassiou M
ACS Chem Neurosci; 2017 Oct; 8(10):2159-2167. PubMed ID: 28792725
[TBL] [Abstract][Full Text] [Related]
29. Metabolism of the synthetic cannabinoid 5F-PY-PICA by human and rat hepatocytes and identification of biliary analytical targets by directional efflux in sandwich-cultured rat hepatocytes using UHPLC-HR-MS/MS.
Mardal M; Annaert P; Noble C; Oorts M; Linnet K
J Pharm Biomed Anal; 2018 Feb; 149():296-307. PubMed ID: 29128830
[TBL] [Abstract][Full Text] [Related]
30. Detection of a New Tert-Leucinate Synthetic Cannabinoid 5F-MDMB-PICA and Its Metabolites in Human Hair: Application to Authentic Cases.
Shi Y; Zhou L; Li L; Liu M; Qiang H; Shen M; Shen B; Chen H; Drummer OH; Liu W; Wu H; Xiang P
Front Chem; 2020; 8():610312. PubMed ID: 33330406
[TBL] [Abstract][Full Text] [Related]
31. The synthetic cannabinoid 5F-MDMB-PICA enhances the metabolic activity and angiogenesis in human brain microvascular endothelial cells by upregulation of VEGF, ANG-1, and ANG-2.
Al-Eitan LN; Alahmad SZ; ElMotasem MFM; Alghamdi MA
Toxicol Res (Camb); 2023 Oct; 12(5):796-806. PubMed ID: 37915478
[TBL] [Abstract][Full Text] [Related]
32. Clinical symptoms and blood concentration of new psychoactive substances (NPS) in intoxicated and hospitalized patients in the Budapest region of Hungary (2018-19).
Institóris L; Kovács K; Sija É; Berkecz R; Körmöczi T; Németh I; Elek I; Bakos Á; Urbán I; Pap C; Kereszty É
Clin Toxicol (Phila); 2022 Jan; 60(1):18-24. PubMed ID: 34080493
[TBL] [Abstract][Full Text] [Related]
33. Human phase-I metabolism and prevalence of two synthetic cannabinoids bearing an ethyl ester moiety: 5F-EDMB-PICA and EDMB-PINACA.
Giorgetti A; Brunetti P; Haschimi B; Busardò FP; Pelotti S; Auwärter V
Drug Test Anal; 2023 Mar; 15(3):299-313. PubMed ID: 36366743
[TBL] [Abstract][Full Text] [Related]
34. 4F-MDMB-BINACA: A New Synthetic Cannabinoid Widely Implicated in Forensic Casework.
Krotulski AJ; Mohr ALA; Kacinko SL; Fogarty MF; Shuda SA; Diamond FX; Kinney WA; Menendez MJ; Logan BK
J Forensic Sci; 2019 Sep; 64(5):1451-1461. PubMed ID: 31260580
[TBL] [Abstract][Full Text] [Related]
35. [Metabolism of New Psychoactive Substances 4F-MDMB-BUTINACA in Zebrafish].
Yue LN; Xiang P; Song FY; Shen BH; Yan H
Fa Yi Xue Za Zhi; 2021 Aug; 37(4):493-499. PubMed ID: 34726001
[TBL] [Abstract][Full Text] [Related]
36. Metabolism studies of 4'Cl-CUMYL-PINACA, 4'F-CUMYL-5F-PINACA and 4'F-CUMYL-5F-PICA using human hepatocytes and LC-QTOF-MS analysis.
Stalberga D; Ingvarsson S; Bessa G; Maas L; Vikingsson S; Persson M; Norman C; Gréen H
Basic Clin Pharmacol Toxicol; 2023 Mar; 132(3):263-280. PubMed ID: 36544361
[TBL] [Abstract][Full Text] [Related]
37. Death after smoking of fentanyl, 5F-ADB, 5F-MDMB-P7AICA and other synthetic cannabinoids with a bucket bong.
Neukamm MA; Halter S; Auwärter V; Schmitt G; Giorgetti A; Bartel M
Forensic Toxicol; 2024 Jan; 42(1):82-92. PubMed ID: 37300633
[TBL] [Abstract][Full Text] [Related]
38. NPS detection in prison: A systematic literature review of use, drug form, and analytical approaches.
Vaccaro G; Massariol A; Guirguis A; Kirton SB; Stair JL
Drug Test Anal; 2022 Aug; 14(8):1350-1367. PubMed ID: 35355411
[TBL] [Abstract][Full Text] [Related]
39. Neurochemical and Behavioral Characterization after Acute and Repeated Exposure to Novel Synthetic Cannabinoid Agonist 5-MDMB-PICA.
Musa A; Simola N; Piras G; Caria F; Onaivi ES; De Luca MA
Brain Sci; 2020 Dec; 10(12):. PubMed ID: 33353194
[TBL] [Abstract][Full Text] [Related]
40. Going deeper into the toxicokinetics of synthetic cannabinoids: in vitro contribution of human carboxylesterases.
Wagmann L; Stiller RG; Fischmann S; Westphal F; Meyer MR
Arch Toxicol; 2022 Oct; 96(10):2755-2766. PubMed ID: 35788413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
